Surgical treatment of hilar bile duct carcinoma: experience with 25 consecutive hepatectomies.

PubWeight™: 0.87‹?›

🔗 View Article (PMID 12127130)

Published in J Gastrointest Surg on July 19, 2002

Authors

Yoshifumi Kawarada1, Bidhan C Das, Tatsushi Naganuma, Masami Tabata, Hiroki Taoka

Author Affiliations

1: First Department of Surgery, Mie University School of Medicine, Mie, Japan. kawarada@ict.ne.jp

Articles citing this

Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment. Hepatology (2008) 3.95

Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009. World J Gastroenterol (2009) 2.17

Surgical resection of hilar cholangiocarcinoma: analysis of survival and postoperative complications. World J Surg (2007) 1.58

Perihilar cholangiocarcinoma: a surgeon's viewpoint on current topics. J Gastroenterol (2012) 0.92

Perihilar cholangiocarcinoma: Current therapy. World J Gastrointest Pathophysiol (2014) 0.90

Hilar cholangiocarcinoma: controversies on the extent of surgical resection aiming at cure. Int J Colorectal Dis (2014) 0.88

Outcome of surgical resection in Klatskin tumors. World J Gastrointest Oncol (2013) 0.88

Diagnostic and surgical approaches in hilar cholangiocarcinoma. Int J Colorectal Dis (2006) 0.85

Advances in diagnosis and treatment of hilar cholangiocarcinoma -- a review. Med Sci Monit (2013) 0.84

Impact of lymph node micrometastasis in hilar bile duct carcinoma patients. World J Gastroenterol (2006) 0.78

Preoperative evaluation with T-staging system for hilar cholangiocarcinoma. World J Gastroenterol (2007) 0.77

Predictors of long term survival after hepatic resection for hilar cholangiocarcinoma: A retrospective study of 5-year survivors. World J Gastrointest Surg (2016) 0.75

Bile duct surgery in the treatment of hepatobiliary and gallbladder malignancies: effects of hepatic and vascular resection on outcomes. HPB (Oxford) (2015) 0.75

Articles by these authors

Clinicopathological features and prognosis of mucin-producing bile duct tumor and mucinous cystic tumor of the liver: a multi-institutional study by the Japan Biliary Association. J Hepatobiliary Pancreat Sci (2013) 1.42

Human equilibrative nucleoside transporter 1 expression is a strong independent prognostic factor in UICC T3-T4 pancreatic cancer patients treated with preoperative gemcitabine-based chemoradiotherapy. J Hepatobiliary Pancreat Sci (2012) 1.20

Analysis of the relationships between clinicopathologic factors and survival time in intrahepatic cholangiocarcinoma. Am J Surg (2002) 1.05

Laparoscopic splenectomy for a huge splenic cyst without preoperative drainage: report of a case. Surg Laparosc Endosc Percutan Tech (2003) 1.03

Pancreaticoduodenectomy with resection of the splenic artery and splenectomy for pancreatic double cancers after total gastrectomy. Preservation of the pancreatic function via the blood supply from the posterior epiploic artery: report of a case. Surg Today (2011) 0.98

Development of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) after pancreaticoduodenectomy: proposal of a postoperative NAFLD scoring system. J Hepatobiliary Pancreat Sci (2009) 0.93

Laparoscopic spleen-preserving pancreatic tail resection for an intrapancreatic accessory spleen mimicking a nonfunctioning endocrine tumor: report of a case. Surg Today (2004) 0.93

Surgical treatment of type IV choledochal cysts. J Hepatobiliary Pancreat Surg (2009) 0.89

Clinical practice guidelines for the management of biliary tract cancers 2015: the 2nd English edition. J Hepatobiliary Pancreat Sci (2015) 0.88

Primary non-Hodgkin's lymphoma of the gallbladder diagnosed by laparoscopic cholecystectomy. J Hepatobiliary Pancreat Surg (2008) 0.87

Intrahepatic hepatic vein stenosis after living-related liver transplantation treated by insertion of an expandable metallic stent. Am J Transplant (2004) 0.87

Monitoring peripheral blood CD4+ adenosine triphosphate activity after living donor liver transplantation: impact of combination assays of immune function and CYP3A5 genotype. J Hepatobiliary Pancreat Sci (2011) 0.87

The role of living-donor liver transplantation in surgical treatment for hepatocellular carcinoma. J Hepatobiliary Pancreat Surg (2006) 0.86

Donor outcome and liver regeneration after right-lobe graft donation. Transpl Int (2005) 0.85

Activated protein C prevents hepatic ischaemia-reperfusion injury in rats. Liver Int (2008) 0.85

A standardized technique for safe pancreaticojejunostomy: Pair-Watch suturing technique. World J Gastrointest Surg (2010) 0.84

Gemcitabine-based chemoradiotherapy followed by surgery for borderline resectable and locally unresectable pancreatic ductal adenocarcinoma: significance of the CA19-9 reduction rate and intratumoral human equilibrative nucleoside transporter 1 expression. Pancreas (2014) 0.84

Outflow block secondary to stenosis of the inferior vena cava following living-donor liver transplantation? Clin Transplant (2005) 0.84

Benefit of technetium-99m galactosyl human serum albumin scintigraphy instead of indocyanine green test in patients scheduled for hepatectomy. Hepatol Res (2014) 0.83

Tissue factor expression demonstrates severe sinusoidal endothelial cell damage during rejection after living-donor liver transplantation. J Hepatobiliary Pancreat Surg (2009) 0.83

Using a radial artery as an interpositional vascular graft in a living-donor liver transplantation for hepatocellular carcinoma. Transpl Int (2005) 0.82

Prospective study on the outcome of patients with hepatocellular carcinoma registered for living donor liver transplantation: how long can they wait? Transplantation (2010) 0.81

Total vascular hepatic exclusion for tumor resection: a new approach to the intrathoracic inferior vena cava through the abdominal cavity by cutting the diaphragm vertically without cutting the pericardium. J Hepatobiliary Pancreat Sci (2010) 0.81

Hepatic mucosa-associated lymphoid tissue (MALT) lymphoma associated with hepatitis C. J Hepatol (2002) 0.81

Anterior approach to the superior mesenteric artery by using nerve plexus hanging maneuver for borderline resectable pancreatic head carcinoma. J Gastrointest Surg (2014) 0.80

Proposal for a morphological classification of intraductal papillary neoplasm of the bile duct (IPN-B). J Hepatobiliary Pancreat Sci (2013) 0.80

Direct hemoperfusion with polymyxin-B-immobilized fiber columns improves septic hypotension and reduces inflammatory mediators in septic patients with colorectal perforation. Langenbecks Arch Surg (2008) 0.80

Successful laparoscopic splenectomy after living-donor liver transplantation for thrombocytopenia caused by antiviral therapy. World J Gastroenterol (2008) 0.80

The right hepatic artery syndrome. World J Gastroenterol (2005) 0.80

Laparoscopy assisted middle-segment-preserving pancreatectomy for multiple pancreatic neuroendocrine tumors: report of a case. Asian J Endosc Surg (2014) 0.80

Paradoxical impact of the remnant pancreatic volume and infectious complications on the development of nonalcoholic fatty liver disease after pancreaticoduodenectomy. J Hepatobiliary Pancreat Sci (2014) 0.80

Approach to fine-needle aspiration cytology-negative cases of breast cancer. Asian J Surg (2005) 0.79

Early graft hemodynamics in living related liver transplantation evaluated by Doppler ultrasonography. Int J Mol Med (2004) 0.79

The cytoprotective effects of addition of activated protein C into preservation solution on small-for-size grafts in rats. Liver Transpl (2010) 0.79

Dual cytoprotective effects of splenectomy for small-for-size liver transplantation in rats. Liver Transpl (2012) 0.79

Maximizing venous outflow after right hepatic living donor liver transplantation with a venous graft patch. Dig Surg (2008) 0.78

Immunological aspects in late phase of living donor liver transplant patients: usefulness of monitoring peripheral blood CD4+ adenosine triphosphate activity. Clin Dev Immunol (2013) 0.78

Impact of histological response after neoadjuvant chemoradiotherapy on recurrence-free survival in UICC-T3 pancreatic adenocarcinoma but not in UICC-T4. Pancreas (2012) 0.77

[A case of primary leiomyosarcoma of the small bowel with hepatic portal venous gas]. Nihon Shokakibyo Gakkai Zasshi (2010) 0.77

Bacterial analysis of infected pancreatic necrosis and its prevention (Symposium 8: Pancreatobiliary infection (IHPBA)). J Hepatobiliary Pancreat Surg (2003) 0.77

Liver retransplantation with external biliary diversion for progressive familial intrahepatic cholestasis type 1: a case report. Pediatr Transplant (2008) 0.76

[A case of anorectal melanoma localized in mucosa]. Nihon Shokakibyo Gakkai Zasshi (2012) 0.75

An approach to the intra-thoracic inferior vena cava through the abdominal cavity preparing for total hepatic vascular exclusion by sagittal diaphragmotomy. Hepatogastroenterology (2013) 0.75

[A case of pancreatic mucinous carcinoma with special reference to diagnostic usefulness of contrast enhanced ultrasonography]. Nihon Shokakibyo Gakkai Zasshi (2011) 0.75

[Studies on the distribution of doripenem in pancreatic tissues, especially on the importance of the ratio in pancreatic tissue concentration of doripenem/serum concentration of doripenem]. Jpn J Antibiot (2014) 0.75

Prolonged thrombocytopenia after living donor liver transplantation is a strong prognostic predictor irrespective of splenectomy: the significance of ADAMTS13 and graft function [corrected]. Int J Hematol (2014) 0.75

[A case report of advanced gastric remnant cancer treated with extended resection accompanied with reconstructions of the portal vein and the hepatic artery with resultant disease free survival for one year and eight months]. Nihon Shokakibyo Gakkai Zasshi (2005) 0.75

Lethal hepatic infarction following plasma exchange in living donor liver transplant patients. Transpl Int (2011) 0.75

[A case of calcifying fibrous tumor in the abdominal wall, morphologically resembling a gastric submucosal tumor]. Nihon Shokakibyo Gakkai Zasshi (2014) 0.75

Combination assays for evaluation of immune function and CYP3A5 genotype to identify the risk of infectious complications and mortality in living donor liver transplant patients. Ann Transplant (2013) 0.75

Multicenter phase II study of modified FOLFOX6 as neoadjuvant chemotherapy for patients with unresectable liver-only metastases from colorectal cancer in Japan: ROOF study. Int J Clin Oncol (2012) 0.75

[A Case of Primary Peritoneal Cancer Successfully Treated with Debulking Surgery and Postoperative Chemotherapy]. Gan To Kagaku Ryoho (2016) 0.75

[A case of polyp-type ampullary carcinoma-in-adenoma within the ampullary channel, displaying an intraductal growth pattern]. Nihon Shokakibyo Gakkai Zasshi (2015) 0.75

Management of advanced pancreatic cancer: staging laparoscopy and immunochemotherapy--a new treatment strategy. Hepatogastroenterology (2002) 0.75

Effect of a prostaglandin I(2) analog on the expression of thrombomodulin in liver and spleen endothelial cells after an extensive hepatectomy. Surg Today (2011) 0.75

Hepaticojejunostomy by interventional radiology with an expandable metallic stent after extended right hepatectomy for hilar cholangiocarcinoma: case report. Surg Laparosc Endosc Percutan Tech (2008) 0.75